OSCR

From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma : FROST: multimodal treatment for GBM recurrence.

Overview

Authors: Jean-Baptiste Barbe-Richaud1, Hélène Cebula2, Julien Todeschi2, Marie des Neiges Santin2, Seyyid Baloglu3, Roland Schott1, Mathieu Cotton4, Aurélien Blouet5, Maxime Bobin5, Georges Noël6, Laura Somme1
  1. Oncology Department, Institut de Cancérologie Strasbourg Europe,17 Rue Albert Calmette, Strasbourg, 67200 France
  2. Neurosurgery Department, Hôpitaux Universitaires de Strasbourg,1 Avenue Molière, Strasbourg, 67200 France
  3. Neuro-Radiology Department, Hôpitaux Universitaires de Strasbourg,1 Avenue Molière, Strasbourg, 67200 France
  4. Pharmaceutic Department, Institut de Cancérologie Strasbourg Europe,17 Rue Albert Calmette, Strasbourg, 67200 France
  5. Radiotherapy Department, Centre d’Oncologie du Pays Basque, 83 Avenue du 14 Avril 1814, Bayonne, 64100 France
  6. Radiotherapy Department, Institut de Cancérologie Strasbourg Europe,17 Rue Albert Calmette, Strasbourg, 67200 France
Journal: Journal of neuro-oncology, volume 178, issue 3, article 73
Dates: received 20 March 2026; accepted 14 May 2026; published online 23 June 2026; in print 2026
Type: Research article · Language: English
License: CC BY-NC-ND
Identifiers: DOI 10.1007/s11060-026-05635-y · PMID 42334687 · PMCID PMC13290778 · OpenAlex W7165535027
Open access: hybrid, a free copy (OpenAlex)
Status: code on request (how the code is found and verified)
Categories: human (organism), other condition (population), clinical / translational (subfield)
Methods: Statistics
Keywords: Glioblastoma, Recurrence, Chemotherapy, Radiotherapy, Surgery, Multimodal
MeSH: Brain Neoplasms*, Glioblastoma*, Neoplasm Recurrence, Local*, Adult, Aged, Antineoplastic Agents, Alkylating, Chemoradiotherapy, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Male, Middle Aged, Retrospective Studies, Temozolomide (* major topic)
Topic: Glioma Diagnosis and Treatment (Oncology, Medicine), according to OpenAlex
Citations: not cited yet (Europe PMC); 49 references in the paper

Abstract

The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.

Code

The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.

Data

No dataset and no data link were found in the paper.

Code and data availability statement

The paper has a code and data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:

  • it says that the data are available on request
  • it says that the code is available on request

Read it in the paper: doi.org/10.1007/s11060-026-05635-y.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Publisher: n/a → Springer Science+Business Media

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 11 authors, 6 keywords, 15 MeSH terms, 49 references.

Cite

This paper

Barbe-Richaud, J.-B., Cebula, H., Todeschi, J., Santin, M. d. N., Baloglu, S., Schott, R., Cotton, M., Blouet, A., Bobin, M., Noël, G., & Somme, L. (2026). From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma : FROST: multimodal treatment for GBM recurrence. Journal of neuro-oncology, 178(3), 73. https://doi.org/10.1007/s11060-026-05635-y

BibTeX

@article{barberichaud2026relapse,
author = {Barbe-Richaud, Jean-Baptiste and Cebula, Hélène and Todeschi, Julien and Santin, Marie des Neiges and Baloglu, Seyyid and Schott, Roland and Cotton, Mathieu and Blouet, Aurélien and Bobin, Maxime and Noël, Georges and Somme, Laura},
title = {{From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma : FROST: multimodal treatment for GBM recurrence}},
journal = {Journal of neuro-oncology},
year = {2026},
month = jun,
volume = {178},
number = {3},
pages = {73},
publisher = {Springer Science+Business Media},
issn = {0167-594X},
doi = {10.1007/s11060-026-05635-y},
url = {https://doi.org/10.1007/s11060-026-05635-y},
pmid = {42334687},
pmcid = {PMC13290778}
}

RIS

TY - JOUR
AU - Barbe-Richaud, Jean-Baptiste
AU - Cebula, Hélène
AU - Todeschi, Julien
AU - Santin, Marie des Neiges
AU - Baloglu, Seyyid
AU - Schott, Roland
AU - Cotton, Mathieu
AU - Blouet, Aurélien
AU - Bobin, Maxime
AU - Noël, Georges
AU - Somme, Laura
TI - From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma : FROST: multimodal treatment for GBM recurrence
T2 - Journal of neuro-oncology
J2 - J Neurooncol
PY - 2026
DA - 2026/06/23
VL - 178
IS - 3
SP - 73
SN - 0167-594X
PB - Springer Science+Business Media
DO - 10.1007/s11060-026-05635-y
UR - https://doi.org/10.1007/s11060-026-05635-y
LA - en
ER -

CSL-JSON

{
"id": "10.1007/s11060-026-05635-y",
"type": "article-journal",
"title": "From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma : FROST: multimodal treatment for GBM recurrence",
"container-title": "Journal of neuro-oncology",
"author": [
{
"family": "Barbe-Richaud",
"given": "Jean-Baptiste"
},
{
"family": "Cebula",
"given": "Hélène"
},
{
"family": "Todeschi",
"given": "Julien"
},
{
"family": "Santin",
"given": "Marie des Neiges"
},
{
"family": "Baloglu",
"given": "Seyyid"
},
{
"family": "Schott",
"given": "Roland"
},
{
"family": "Cotton",
"given": "Mathieu"
},
{
"family": "Blouet",
"given": "Aurélien"
},
{
"family": "Bobin",
"given": "Maxime"
},
{
"family": "Noël",
"given": "Georges"
},
{
"family": "Somme",
"given": "Laura"
}
],
"container-title-short": "J Neurooncol",
"volume": "178",
"issue": "3",
"page": "73",
"DOI": "10.1007/s11060-026-05635-y",
"PMID": "42334687",
"PMCID": "PMC13290778",
"ISSN": "0167-594X",
"publisher": "Springer Science+Business Media",
"URL": "https://doi.org/10.1007/s11060-026-05635-y",
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
23
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1007/s11011-023-01234-2
Novel sights on therapeutic, prognostic, and diagnostics aspects of non-coding RNAs in glioblastoma multiforme.
Journal: Metabolic brain disease
In common: clinical / translational, other condition, 7 references
[2] doi:10.3390/pharmaceutics15041134
The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma.
Journal: Pharmaceutics
In common: clinical / translational, other condition, 7 references
[3] doi:10.1016/j.cell.2026.05.026 [code]
The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM.
Journal: Cell
In common: other condition, 6 references
[4] doi:10.3389/fphar.2022.1072253
Serine and glycine metabolism-related gene expression signature stratifies immune profiles of brain gliomas, and predicts prognosis and responses to immunotherapy.
Journal: Frontiers in pharmacology
In common: other condition, 6 references
[5] doi:10.1038/s41591-025-03512-1 [code]
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma.
Journal: Nature medicine
In common: clinical / translational, other condition, 5 references
[6] doi:10.3389/fphar.2022.1061597
Prognosis prediction and tumor immune microenvironment characterization based on tryptophan metabolism-related genes signature in brain glioma.
Journal: Frontiers in pharmacology
In common: other condition, 5 references
[7] doi:10.1158/1078-0432.ccr-25-4419 [code]
Framework for Statistical Parametric Mapping of the Interactions between Glioblastoma Location, Treatment, Prognostic Variables, and Survival Using a Phase III Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
In common: clinical / translational, other condition, 5 references
[8] doi:10.3390/biomedicines11041219
Transcriptional Profiling of a Patient-Matched Cohort of Glioblastoma (IDH-Wildtype) for Therapeutic Target and Repurposing Drug Identification.
Journal: Biomedicines
In common: clinical / translational, other condition, 5 references
[9] doi:10.1186/s13578-024-01218-4 [code]
Revealing the role of SPP1<sup>+</sup> macrophages in glioma prognosis and therapeutic targeting by investigating tumor-associated macrophage landscape in grade 2 and 3 gliomas.
Journal: Cell & bioscience
In common: clinical / translational, other condition, 4 references
[10] doi:10.1038/s12276-026-01801-4 [code]
Putative glioblastoma origin-like cells in the subventricular zone: isolation and characterization.
Journal: Experimental & molecular medicine
In common: other condition, 4 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.